These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 27374726)

  • 1. Activity of linezolid and tedizolid against clinical isolates of methicillin-resistant and methicillin and linezolid resistant Staphylococcus aureus: an in vitro comparison.
    Peñuelas M; Candel FJ; Lejarraga C; López-González L; Viñuela-Prieto JM; López de Mendoza D
    Rev Esp Quimioter; 2016 Oct; 29(5):255-8. PubMed ID: 27374726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates.
    Candel FJ; Morales G; Picazo JJ
    Rev Esp Quimioter; 2011 Sep; 24(3):127-30. PubMed ID: 21947094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial Activity of Tedizolid, a Novel Oxazolidinone Against Methicillin-Resistant
    Hasannejad-Bibalan M; Mojtahedi A; Biglari H; Halaji M; Sedigh Ebrahim-Saraie H
    Microb Drug Resist; 2019 Nov; 25(9):1330-1337. PubMed ID: 31290721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro activities of Tedizolid and comparator antimicrobial agents against clinical isolates of Staphylococcus aureus collected in 12 countries from 2014 to 2016.
    Karlowsky JA; Hackel MA; Bouchillon SK; Alder J; Sahm DF
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):151-157. PubMed ID: 28793964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
    Barber KE; Smith JR; Raut A; Rybak MJ
    J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of tedizolid and other comparator drugs in methicillin-resistant Staphylococcus aureus isolates in skin and soft tissue infections in seven Colombian hospitals.
    Leal AL; Ovalle MV; Cortés JA; Montañes AM; De la Rosa ZR; Rodríguez JY; Gualtero S; Ariza B; Sussman O; Torres MDP
    Biomedica; 2018 Dec; 38(4):507-513. PubMed ID: 30653864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity and microbiological efficacy of tedizolid (TR-700) against Gram-positive clinical isolates from a phase 2 study of oral tedizolid phosphate (TR-701) in patients with complicated skin and skin structure infections.
    Prokocimer P; Bien P; Deanda C; Pillar CM; Bartizal K
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4608-13. PubMed ID: 22687509
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Pfaller MA; Sader HS; Rhomberg PR; Flamm RK; Mendes RE
    Microb Drug Resist; 2019; 25(6):938-943. PubMed ID: 30694735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative activity of tedizolid against clinical isolates of linezolid-resistant coagulase-negative staphylococci and methicillin-resistant Staphylococcus aureus.
    Pérez-Parra S; Peña-Monje A; Recio JL; García-García F
    Enferm Infecc Microbiol Clin; 2017 May; 35(5):323-324. PubMed ID: 27743684
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro activity of tedizolid against clinical isolates of Staphylococcus lugdunensis and Staphylococcus haemolyticus from Europe and the United States.
    Farrell DJ; Mendes RE; Bensaci M
    Diagn Microbiol Infect Dis; 2019 Jan; 93(1):85-88. PubMed ID: 30314652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates from skin and soft tissue infections to vancomycin, daptomycin, linezolid and tedizolid.
    Vanegas Múnera JM; Ocampo Ríos AM; Urrego DM; Jiménez Quiceno JN
    Braz J Infect Dis; 2017; 21(5):493-499. PubMed ID: 28432878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci.
    Rodríguez-Avial I; Culebras E; Betriu C; Morales G; Pena I; Picazo JJ
    J Antimicrob Chemother; 2012 Jan; 67(1):167-9. PubMed ID: 21954458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacies of human simulated exposures of tedizolid and linezolid against Staphylococcus aureus in the murine thigh infection model.
    Keel RA; Tessier PR; Crandon JL; Nicolau DP
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4403-7. PubMed ID: 22687504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection setting.
    Abad L; Tafani V; Tasse J; Josse J; Chidiac C; Lustig S; Ferry T; Diot A; Laurent F; Valour F
    J Antimicrob Chemother; 2019 Mar; 74(3):625-632. PubMed ID: 30517641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vitro evaluation of the efficacy of tedizolid: implications for the treatment of skin and soft tissue infections.
    Delpech P; ALeryan M; Jones B; Gemmell C; Lang S
    Diagn Microbiol Infect Dis; 2018 May; 91(1):93-97. PubMed ID: 29452993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
    Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S
    J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subinhibitory concentrations of tedizolid potently inhibit extracellular toxin production by methicillin-sensitive and methicillin-resistant Staphylococcus aureus.
    Katahira EJ; Davidson SM; Stevens DL; Bolz DD
    J Med Microbiol; 2019 Feb; 68(2):255-262. PubMed ID: 30556803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain.
    Betriu C; Morales G; Rodríguez-Avial I; Culebras E; Gómez M; López-Fabal F; Picazo JJ
    Antimicrob Agents Chemother; 2010 May; 54(5):2212-5. PubMed ID: 20176900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus.
    Morales G; Picazo JJ; Baos E; Candel FJ; Arribi A; Peláez B; Andrade R; de la Torre MA; Fereres J; Sánchez-García M
    Clin Infect Dis; 2010 Mar; 50(6):821-5. PubMed ID: 20144045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the pharmacodynamic interactions between tedizolid and other orally bioavailable antimicrobials against Staphylococcus aureus and Staphylococcus epidermidis.
    Werth BJ
    J Antimicrob Chemother; 2017 May; 72(5):1410-1414. PubMed ID: 28158617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.